Kyowa Kirin Co., Ltd.: all 233 studies

Page 1 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• A Phase 1/2 Study of KK2430 in Participants With Hematologic NeoplasmsRecruitingNCT07629726Phase 1/2
• A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid LeukemiaRecruitingNCT07623616Phase 2
• A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaRecruitingNCT07192471Phase 1
• Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result SurveillanceRecruitingNCT07132567
• Study of KK3910 in Healthy Volunteers and Patients With Essential HypertensionRecruitingNCT06823947Phase 1
• Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.RecruitingNCT06812104Phase 1
• A First-in-human Study of KK8123 in Adults With X-linked HypophosphatemiaRecruitingNCT06525636Phase 1/2
• A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06248411Phase 1
• Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean PatientsRecruitingNCT06202027
• Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsRecruitingNCT06186934
• Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With MogamulizumabRecruitingNCT04014374
• Expanded Access to BurosumabAvailableNCT03775187
• Registry for Patients With X-Linked HypophosphatemiaRecruitingNCT03193476
• Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT03703102Phase 2Results posted
• Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary HyperparathyroidismCompletedNCT03280264Phase 3Results posted
• Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLHCompletedNCT02915705Phase 3Results posted
• Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)CompletedNCT02750618Phase 2Results posted
• Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid TumorsCompletedNCT02705105Phase 1/2Results posted
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative ColitisCompletedNCT02647866Phase 2Results posted
• Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedNCT02610231Phase 3Results posted
• Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02537431Phase 3Results posted
• Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)CompletedNCT02526160Phase 3Results posted
• Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung CancerCompletedNCT02358473Phase 1Results posted
• Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)CompletedNCT02312687Phase 2Results posted
• Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)CompletedNCT02304367Phase 2Results posted
• Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)CompletedNCT02163577Phase 2Results posted
• A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic AnemiaCompletedNCT02094417Phase 2Results posted
• A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedNCT01968031Phase 3Results posted
• Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCLCompletedNCT01728805Phase 3Results posted
• KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)CompletedNCT01626664Phase 2Results posted
• An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01571596Phase 1/2Results posted
• A Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01340482Phase 1/2Results posted
• Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001CompletedNCT01226472Phase 2Results posted
• A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple MyelomaCompletedNCT01063907Phase 1/2Results posted
• Phase II Study of KW-0761 in Subjects With CCR4-positive Adult T-cell Leukemia-lymphomaCompletedNCT00920790Phase 2Results posted
• Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell LymphomaCompletedNCT00888927Phase 1/2Results posted
• Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerTerminatedNCT00838578Phase 1/2Results posted
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITPCompletedNCT00440037Phase 2/3Results posted
• Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCLCompletedNCT00355472Phase 1Results posted
• An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous LeukemiaTerminatedNCT00346632Phase 1Results posted
• Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer PatientsCompletedNCT00263575Phase 3Results posted
• An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001TerminatedNCT00199381Phase 3Results posted
• Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）Active, not recruitingNCT06926491Phase 3
• A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic TherapyCompletedNCT06285370Phase 4
• A Study of KK2269 in Adult Participants With Solid TumorsActive, not recruitingNCT06266299Phase 1
• A Study to Investigate the Efficacy and Safety of OTL-203 in Subjects With MPS-IH Compared With Standard of Care With Allogeneic HSCTActive, not recruitingNCT06149403Phase 3
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular EdemaActive, not recruitingNCT06116916Phase 2
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT06116890Phase 2
• Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune FunctionActive, not recruitingNCT06094153Not applicable
• Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)CompletedNCT05455931
• A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus ErythematosusCompletedNCT05411016Phase 1
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIOCompletedNCT05357573Phase 4
• A Study to Describe the Lived Experience of XLH for Adolescents at End of Skeletal GrowthCompletedNCT05181839
• Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches.CompletedNCT05027646Phase 1
• A Study of KRN125 in Patients With Multiple Myeloma and Malignant LymphomaCompletedNCT05007652Phase 2
• Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic AnemiaActive, not recruitingNCT04870346
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLHCompletedNCT04842032Phase 4
• Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLHCompletedNCT04842019Phase 4
• A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLHCompletedNCT04819490
• Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04771780Phase 3
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04767581Phase 3
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04766398Phase 3
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal DialysisCompletedNCT04766385Phase 3
• Mogamulizumab Q4week Dosing in Participants With R/R CTCLActive, not recruitingNCT04745234Phase 2
• A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque PsoriasisWithdrawnNCT04614298Phase 4
• A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular DegenerationTerminatedNCT04594681Phase 1
• Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Active, not recruitingNCT04533581Phase 2
• A Study of KHK4827 in Patients With Systemic SclerosisCompletedNCT04368403Phase 1
• A Through QT/QTc Study of KW-6356CompletedNCT04342273Phase 1
• Expanded Access for KHK2455No longer availableNCT04321694
• A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT04308096Phase 3
• OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)Active, not recruitingNCT04283227Phase 3
• Pharmacokinetic Study of KHK7580 in Healthy Adult VolunteersCompletedNCT04206657Phase 1
• Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major MetaboliteCompletedNCT04190654Phase 1
• Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of AgeCompletedNCT04188964Phase 1/2
• A Phase 4 Clinical Study of BrodalumabCompletedNCT04183881Phase 4
• KW-3357 Study in Patients With Early Onset Severe PreeclampsiaCompletedNCT04182373Phase 3
• Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With NaloxegolCompletedNCT04173858
• Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356CompletedNCT04147910Phase 1
• Study of AMG531 (Romiplostim) in Patients With Aplastic AnemiaCompletedNCT04095936Phase 2/3
• A Drug Interaction Study of KW-6356 and Clarithromycin or RifampicinCompletedNCT04070495Phase 1
• A Study of KHK4827 in Subjects With Palmoplantar PustulosisCompletedNCT04061252Phase 3
• A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy AdultsCompletedNCT04023903Phase 1
• A Study of RTA 402 in Obese AdultsCompletedNCT04018339Phase 1
• KRN125 for Mobilization of Hematopoietic Stem CellsCompletedNCT03993639Phase 2
• Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT03985189Phase 1
• A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or RosuvastatinCompletedNCT03970798Phase 1
• Study of AMG531(Romiplostim) in Patients With Aplastic AnemiaCompletedNCT03957694Phase 2/3
• A Phase 3 Study of KHK4827 in Patients With Systemic SclerosisCompletedNCT03957681Phase 3
• Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLHCompletedNCT03920072Phase 3
• KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder CancerTerminatedNCT03915405Phase 1
• Dose-finding Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864458Phase 2
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864445Phase 2
• Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic DermatitisTerminatedNCT03846466Phase 1
• A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HDCompletedNCT03831607Phase 2
• A Study of Single and Multiple Doses of KW-6356 in Healthy SubjectsCompletedNCT03830528Phase 1
• Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedNCT03822507Phase 3
• Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian PartnersActive, not recruitingNCT03745521
• A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing PreparationsCompletedNCT03703570Phase 2
• Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC.CompletedNCT03638440

← Kyowa Kirin Co., Ltd. overview and focus areas